Trial Profile
A study of rasagiline to evaluate the effect on lower urinary tract (LUT) behavior in patients with Parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Rasagiline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 17 Dec 2015 New trial record